S-1/A: AtlasClear Holdings Files Amendment No. 2 to Form S-1, Registering Resale of Up to 51.9 Million Shares

Sentiment:

S-1/A Filing


AtlasClear Holdings files an amendment to its Form S-1 registration statement, covering the potential resale of up to 51,877,099 shares of its common stock by selling stockholders.

Capital raiseThe document references a non-binding term sheet with Tau, where Tau would commit to purchase up to $10 million of Common Stock of the Company over the course of 24 months from the date of entry into a definitive agreement.
Worse than expectedThe potential resale of a large number of shares could significantly decrease the public trading price of the common stock.Certain selling stockholders may experience a positive rate of return even if the market price is below $10.00, while public stockholders may not.

Summary

  • AtlasClear Holdings has filed Amendment No. 2 to its Form S-1 registration statement with the SEC.
  • The filing covers the potential resale of up to 51,877,099 shares of the company's common stock by selling stockholders.
  • These shares consist of merger consideration shares, shares issuable to Wilson-Davis sellers, shares issuable to Pacsquare, shares issued to Commercial Bancorp shareholders, shares issuable to Chardan, shares issuable to Funicular, shares issued to Qvent LLC, shares issued to Calabrese Consulting LLC, shares issued to Grant Thornton LLP, shares issued to IB Capital LLC, shares issued to Outside The Box Capital Inc., shares issuable to Carriage House Capital, Inc., shares issuable to Interest Solutions, LLC, shares issuable to JonesTrading Institutional Services LLC, shares issuable to Winston & Strawn LLP, shares issuable to Lead Nectar, and shares issuable to Tau.
  • The company will not receive any proceeds from the sale of these shares by the selling stockholders.
  • As of July 15, 2024, the number of shares of Common Stock that may be offered for resale by the Selling Stockholders pursuant to this prospectus is almost 4.17 times larger than the number of outstanding shares of Common Stock.
  • On July 15, 2024, the last sale price of the Common Stock as reported on the NYSE was $0.72 per share.

Sentiment

Score: 3

Explanation: The document is primarily a registration statement, which is inherently neutral. However, the potential for significant dilution and the fact that some selling stockholders may profit even if the share price is low introduces a negative element.

Negatives

  • The potential resale of a large number of shares could significantly decrease the public trading price of the common stock.
  • Certain selling stockholders may experience a positive rate of return even if the market price is below $10.00, while public stockholders may not.

Risks

  • Future sales, or the perception of future sales, by the company or its stockholders could cause the market price for the Common Stock to decline.
  • The shares of our Common Stock being registered for resale are anticipated to constitute a considerable percentage of our public float.
  • A significant portion of the shares of our Common Stock being registered for resale may be acquired by Selling Stockholders at prices below the current market price of our Common Stock.
  • This discrepancy in purchase prices may have an impact on the market perception of our Common Stocks value and could increase the volatility of the market price of our Common Stock or result in a significant decline in the public trading price of our Common Stock.
  • The registration of these shares for resale creates the possibility of a significant increase in the supply of our Common Stock in the market.
  • The increased supply, coupled with the potential disparity in purchase prices, may lead to heightened selling pressure, which could negatively affect the public trading price of our Common Stock.

Future Outlook

The registration of the resale of the Offered Shares does not mean that the Selling Stockholders will offer or sell any of the Offered Shares.

Industry Context

The document does not provide specific details about the broader industry trends or competitors, but it implies that AtlasClear Holdings aims to provide a more efficient and technologically advanced platform compared to existing solutions.

Stakeholder Impact

  • Shareholders: Potential dilution and decline in share price.
  • Employees: Stock trading volatility could impact our ability to recruit and retain employees.

Next Steps

  • The selling stockholders may offer and sell the securities covered by this prospectus in a number of different ways and at varying prices.
  • The Company may need to register additional shares for resale.

Key Dates

DateDescription
April 15, 2022Date of the Stock Purchase Agreement by and among Wilson-Davis & Co., Inc., all of its Stockholders and AtlasClear, Inc.
September 13, 2023Date of the Marketing Services Agreement between OTB and Quantum.
February 9, 2024Date of the Business Combination.
February 9, 2024Date of the Funicular Purchase Agreement.
February 9, 2024Date of the Chardan Note issuance.
February 9, 2024Date of the Winston & Strawn Agreement.
February 12, 2024Common Stock commenced trading on the NYSE under the symbol ATCH.
February 12, 2024AtlasClear Holdings warrants commenced trading on the OTC under the symbol ATCHW.
February 16, 2024Date of the Pacsquare Purchase Agreement.
February 19, 2024Date of the Consulting Agreement between Carriage and the Company.
February 26, 2024Date of the Amendment to the Bank Acquisition Agreement.
April 4, 2024Date of the Satisfaction and Discharge Agreement between Calabrese and the Company.
April 29, 2024Date of the non-binding ELOC Term Sheet between the Company and Tau.
August 9, 2024First installment date for payment of legal services to Winston & Strawn LLP.
February 9, 2028Stated maturity date of the Chardan Note.

Keywords

common stock, resale, registration statement, selling stockholders, AtlasClear Holdings, shares

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.